Patents by Inventor Gail Dianne Phillips

Gail Dianne Phillips has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180282428
    Abstract: Anti-ErbB2 antibodies are described which bind to an epitope in Domain 1 of ErbB2 and induce cell death via apoptosis. Various uses for these antibodies are also described.
    Type: Application
    Filed: June 15, 2018
    Publication date: October 4, 2018
    Applicant: Genentech, Inc.
    Inventors: Brian M. Fendly, Gail Dianne Phillips, Richard Scheuermann, Jonathan W. Uhr
  • Publication number: 20170190786
    Abstract: Anti-ErbB2 antibodies are described which bind to an epitope in Domain 1 of ErbB2 and induce cell death via apoptosis. Various uses for these antibodies are also described.
    Type: Application
    Filed: August 11, 2016
    Publication date: July 6, 2017
    Inventors: Brian M. Fendly, Gail Dianne Phillips, Richard H. Scheuermann, Jonathan W. Uhr
  • Publication number: 20150252113
    Abstract: Anti-ErbB2 antibodies are described which bind to an epitope in Domain 1 of ErbB2 and induce cell death-via apoptosis. Various uses for these antibodies are also described.
    Type: Application
    Filed: October 10, 2014
    Publication date: September 10, 2015
    Inventors: Brian M. FENDLY, Gail Dianne PHILLIPS, Richard H. SCHEUERMANN, Jonathan W. UHR
  • Publication number: 20130195845
    Abstract: Anti-ErbB2 antibodies are described which bind to an epitope in Domain 1 of ErbB2 and induce cell death via apoptosis. Various uses for these antibodies are also described.
    Type: Application
    Filed: March 27, 2012
    Publication date: August 1, 2013
    Inventors: Brian M. Fendly, Gail Dianne Phillips
  • Publication number: 20110033460
    Abstract: Anti-ErbB2 antibodies are described which bind to an epitope in Domain 1 of ErbB2 and induce cell death via apoptosis. Various uses for these antibodies are also described.
    Type: Application
    Filed: October 22, 2010
    Publication date: February 10, 2011
    Inventors: Brian M. Fendly, Gail Dianne Phillips, Richard H. Scheuermann, Jonathan W. Uhr
  • Publication number: 20090098115
    Abstract: The present invention concerns cell lines and animal models of HER2-expressing tumors. In particular, the invention concerns cell lines and animal models of HER2-expressing tumors not responding or responding poorly to treatment with trastuzumab (HERCEPTIN®, Genentech, Inc.). The animal models and cell lines of the invention are useful for evaluating the efficacy of various therapeutic approaches for the treatment of such tumors.
    Type: Application
    Filed: October 19, 2007
    Publication date: April 16, 2009
    Inventors: Lisa Michele Crocker, Sarajane Ross, Gail Dianne Phillips